Dimethylarsenic (DMA) exposure risk assessment delivers a science-based framework for quantifying the human health and ecological risks associated with organoarsenic contamination in freshwater, estuarine, and marine sediments. By integrating high-precision arsenic speciation analysis with site-specific exposure pathway modeling and toxicity evaluation, this assessment supports contaminated site investigation, dredged material management, and remediation decision-making in accordance with internationally recognized standards.
Technical Overview
Dimethylarsenic compounds, principally dimethylarsinic acid (DMA(V)) and its reduced form dimethylarsinous acid (DMA(III)), are methylated organoarsenic species that accumulate in sediments through microbial methylation of inorganic arsenic, historical application of organoarsenical herbicides such as cacodylic acid, and industrial or geothermal discharges. Because the toxicity, mobility, and bioavailability of arsenic vary dramatically among its chemical species, total arsenic measurements alone cannot support defensible risk conclusions. A species-specific evaluation is therefore essential whenever sediments contain significant methylated arsenic fractions.
In anoxic sediments, DMA is governed by sorption onto iron and manganese (oxy)hydroxides, co-precipitation with sulfide minerals, and association with organic matter. Redox shifts caused by dredging, flooding regime changes, or remediation disturbance can remobilize DMA into pore water and the overlying water column, while benthic microorganisms may further methylate it to volatile arsines or transfer it into the aquatic food web. The International Agency for Research on Cancer classifies dimethylarsinic acid as possibly carcinogenic to humans, and chronic rodent studies indicate bladder carcinogenicity at high doses, underscoring the importance of chronic exposure evaluation.
A complete exposure risk assessment couples accredited third-party laboratory speciation data with the risk assessment paradigm recommended by environmental protection agencies: hazard identification, dose-response assessment, exposure assessment, and risk characterization. Outputs include hazard quotients for non-carcinogenic endpoints, incremental lifetime cancer risk estimates, and ecological risk quotients benchmarked against recognized sediment quality guidelines, providing a quantitative basis for site prioritization, remedial design, and regulatory compliance.
Testing Samples
Freshwater River and Lake Sediments
Surficial and core sediments from rivers, reservoirs, and lakes affected by mining drainage, smelting operations, agricultural runoff, or former organoarsenical pesticide use. Depth-discrete cores enable evaluation of historical deposition and vertical redox zoning that controls DMA stability.
Estuarine and Marine Sediments
Sediments from estuaries, harbors, and coastal zones where salinity gradients, tidal flushing, and sulfate reduction influence arsenic methylation and speciation. These matrices frequently contain complex arsenic profiles including DMA, monomethylarsonic acid, trimethylarsine oxide, arsenobetaine, and arsenosugars of biogenic origin.
Contaminated Site Sediments and Dredged Material
Impacted sediments from former pesticide manufacturing plants, wood treatment facilities, coal-fired power plant ash ponds, and candidate dredged spoils. Assessment determines whether material meets open-water disposal criteria, requires confined disposal, or warrants treatment before beneficial reuse.
Pore Water, Elutriates, and Benthic Biota
Interstitial water and water-column exposure media collected to quantify dissolved DMA available for uptake, together with benthic invertebrates and fish tissue samples used to characterize trophic transfer and food-web exposure pathways.
Testing Items
Testing programs are structured to capture both the arsenic speciation signature and the sediment properties that govern DMA mobility and bioavailability:
- Arsenic speciation: As(III), As(V), MMA(V), DMA(V), DMA(III) where detectable, trimethylarsine oxide, arsenobetaine, arsenocholine, and arsenosugars
- Total arsenic and co-occurring metals: As, Cd, Pb, Cu, Zn, Cr, Ni, Hg, Sb, Se, Fe, Mn
- Physicochemical parameters: pH, redox potential (Eh), total organic carbon, grain size distribution, cation exchange capacity, and specific surface area
- Binding-phase characterization: amorphous and crystalline Fe/Mn (oxy)hydroxides, acid-volatile sulfide (AVS), simultaneously extracted metals (SEM), and sequential extraction fractionation
- Bioaccessibility: in vitro gastrointestinal extraction to estimate the orally bioavailable DMA fraction
- Leachability and release potential: TCLP and SPLP leaching tests, and simulated resuspension or elutriate testing for dredging scenarios
Testing Methods
Sampling and Sample Preservation
Bottom sediment sampling follows ISO 5667-12 guidance, with grab or core devices selected according to water depth and sediment texture. Because microbial activity and oxygen exposure can alter arsenic speciation within hours, samples for speciation are immediately sealed under inert atmosphere or nitrogen blankets, protected from light, frozen or refrigerated at 4 °C or below, and analyzed within validated holding times. Chain-of-custody procedures and trip, field, and equipment blanks are applied throughout.
Determination of Total Arsenic
Total arsenic is quantified following US EPA Method 3050B or microwave-assisted US EPA Method 3051A digestion, with detection by ICP-MS per US EPA Method 6020B or ISO 17294-2, or by hydride generation atomic fluorescence spectrometry consistent with GB/T 22105.2. Results are compared against screening benchmarks such as GB 18668 marine sediment quality criteria and widely applied effects-based sediment quality guidelines.
Arsenic Speciation by HPLC-ICP-MS and HPLC-HG-AFS
DMA and co-existing species are separated by anion-exchange high-performance liquid chromatography using mild phosphate- or oxalate-based extraction that preserves the original oxidation states, followed by sector-field or quadrupole ICP-MS detection for multi-species quantification, or by hydride generation atomic fluorescence for cost-effective routine screening. Method performance is verified through spiked recoveries, mass balance against total arsenic, duplicate extractions, and certified reference materials where available.
Bioaccessibility, Leaching, and Release Testing
Orally bioavailable fractions are estimated using physiologically based in vitro gastrointestinal extraction, while leaching behavior is characterized with US EPA Methods 1311 (TCLP) and 1312 (SPLP). For dredging projects, elutriate and resuspension tests simulate short-term DMA release to the water column, and AVS/SEM analysis evaluates the binding capacity of anoxic sediments.
Exposure Assessment and Risk Characterization
Human exposure pathways evaluated include incidental sediment ingestion, dermal contact, inhalation of resuspended particulates, and dietary intake via contaminated fish and shellfish, using exposure algorithms and default parameters from the US EPA Risk Assessment Guidance for Superfund, supplemented by national procedures such as China HJ 25.3-2019 and the risk-based corrective action framework of ASTM E2081. Carcinogenic and non-carcinogenic risks incorporate species-specific toxicity values and relative potency factors that reflect the lower potency of DMA compared with inorganic arsenic. Ecological characterization applies consensus-based sediment quality guideline quotients, toxicity reference values, and food-web accumulation models for benthic and higher-trophic-level receptors.
Applications
Dimethylarsenic exposure risk assessment is applied across environmental management and regulatory compliance contexts wherever methylated arsenic in sediment may threaten receptors or constrain project approval:
- Contaminated site investigation and risk-based remediation planning at former pesticide plants, smelters, mines, and wood-preserving facilities
- Dredged material characterization for navigational, port expansion, and waterway restoration projects, including disposal and beneficial reuse decisions
- Ecological risk evaluation for rivers, lakes, reservoirs, and estuaries within drinking water source protection zones
- Post-remediation verification and long-term monitoring of sediment quality under environmental management agreements
- Due diligence and environmental impact assessment for land and waterfront redevelopment adjacent to arsenic-impacted waterways
- Scientific research on arsenic biogeochemical cycling, methylation dynamics, and climate-driven redox changes
FAQ
Why is speciation analysis necessary instead of measuring only total arsenic?
Toxicity differs by orders of magnitude among arsenic species, and risk criteria are predominantly derived for inorganic arsenic. A sediment whose arsenic burden is largely DMA poses a substantially different hazard than one dominated by As(III), so speciation is indispensable for accurate, legally defensible risk conclusions and for avoiding overly conservative or underestimated remediation requirements.
How is arsenic speciation preserved during sediment sampling?
Speciation can change rapidly through oxidation and continued microbial metabolism. Samples are collected with minimal disturbance, sealed without headspace, kept cold and dark, frozen where validated, and extracted with mild reagents that do not alter species distribution. Accredited third-party laboratories validate these procedures with holding-time studies and mass balance checks.
Which exposure pathways are quantified in the assessment?
Human pathways include incidental ingestion of sediment by children and adults, dermal contact during recreational or occupational activity, inhalation of wind-blown or dredging-generated dust, and dietary exposure through fish and shellfish consumption. Ecological pathways address direct toxicity to benthic organisms, pore water exposure, and trophic transfer through the aquatic food web.
What outcomes indicate unacceptable risk and trigger management action?
Key decision metrics include hazard quotients exceeding 1 for non-carcinogenic endpoints, incremental lifetime cancer risk above the acceptable range of one-in-a-million to one-in-ten-thousand, and ecological quotients exceeding consensus-based probable effect concentrations. Exceedances prompt further investigation, source control, monitored natural recovery, capping, or sediment removal.
Can DMA in sediment naturally attenuate over time?
Yes, to a degree. Microbial communities can further methylate DMA to volatile arsines that diffuse to the atmosphere, and burial under fresh sediment can isolate contaminated layers. However, redox disturbance, dredging, or erosion can remobilize DMA, so monitored natural recovery requires demonstration of stable conditions and ongoing verification monitoring.